Wall Street Analysts Believe Sarepta Therapeutics (SRPT) Could Rally 38.04%: Here's is How to Trade

The mean estimate comprises 17 short-term price targets with a standard deviation of $22. While the lowest estimate of $165 indicates a 14.8% increase from the current price level, the most optimistic analyst expects the stock to surge 63.4% to reach $235. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts. Sarepta Therapeutics (SRPT) closed the last trading session at ...